PATENT CLAIM ANALYSIS

Application Number: 16149218
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "093200"]

Abstract:
Sequences of novel adeno-associated virus capsids and vectors and host cells containing these sequences are provided. Also described are methods of using such host cells and vectors in production of rAAV particles. AAV-mediated delivery of therapeutic and immunogenic genes using the vectors of the invention is also provided.

Claim (Index 18):
A recombinant AAV comprising an AAV8 capsid protein encoded by the recombinant nucleic acid molecule according to  claim 12 .

Metadata:
- Claim Count in Document: 39.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15227418', '15433322', '14803683', '14624671', '10573600']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7894385499157839
- 35 USC 102 Novelty (BERT): 0.5995406894672493
- Combined Prediction Score: 0.7704487638709304
- Mean Citation Score: 493.46115799999984
- Max Citation Score: 576.52875
- Similarity Product: 440.89300991043433

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test